Shares of Clearday (OTCMKTS:CLRD) have been under selling pressure over the past week with a fall of 25%.
Market Reaction
On Friday, CLRD stock ended flat at $3.19 with 256 shares, compared to its average volume of 3.18K shares. The stock has moved within a range of $3.1900 – 3.1900 after opening trade at $3.35.
Clearday™ Provides Company Update
Clearday (OTCMKTS:CLRD) on October 28, 2021, issued a corporate update. The company confirmed that in August 2021 it announced a merger with Allied Integral United.
The firm said that it changed its near to Clearday, Inc after the merger and changed its symbol to ‘CLRD’, one of the many critical milestones achieved by the company to continue with its innovative non-acute care services available as a public company.
Clearday said that it exists with the vision to give transformative new care models extending the capacity of elderly Americans to age in place. With the recent structure, its issued and outstanding shares of common stock become 14,910,000.
The company’s businesses include Clearday at Home, a digital care platform that can be used by Home Care Agencies. This will target approximately 18,000 agencies across America and help them grow as well as provide care. Clearday opines that currently there is just one caregiver for every 43 jobs. Additionally, it has Clearday Clubs designed for an inspiring new kind of daytime destination, making it an ideal place that can be called home. Peaceful and relaxed, the Clubs have ample room for every member for finding the best routine.
James Walesa CEO of Clearday said that the company is proud on launching its digital service in less than a year despite the tough environment. The company has acquired an adult daycare in San Antonio and is developing its flagship adult daycarecenter at its 8800 Village Drive, San Antonio, Texas headquarters.
Key Quote
James Walesa CEO of Clearday stated, “I am pleased to report our successful merger that resulted in Allied Integral United, Inc. going public. We are working on a number of initiatives to adopt innovative therapies, products and services while continuing to service our clients with the upmost care.”
Traders Review
CLRD stock is trading below the 20-Day and 50-Day Moving averages of $3.34 and $3.44 respectively. Moreover, the stock is trading below the 200-Day moving average of $3.72. The stock is down 3% over the past month.
